These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7980847)

  • 21. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-phospholipid antibodies in the mercuric chloride treated brown Norway rat.
    Marriott JB; Qasim F; Oliveira DB
    J Autoimmun; 1994 Aug; 7(4):457-67. PubMed ID: 7980848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of experimental models of systemic lupus erythematosus and antiphospholipid syndrome induced by idiotypic manipulation.
    Shoenfeld Y
    Isr J Med Sci; 1994 Jan; 30(1):10-8. PubMed ID: 8138385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
    Matsuura E
    Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).
    Bakimer R; Fishman P; Blank M; Sredni B; Djaldetti M; Shoenfeld Y
    J Clin Invest; 1992 May; 89(5):1558-63. PubMed ID: 1569194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now?
    Inanç M; Radway-Bright EL; Isenberg DA
    Br J Rheumatol; 1997 Dec; 36(12):1247-57. PubMed ID: 9448584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
    Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
    J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiphospholipid antibody and antiphospholipid antibody syndrome.
    Sugai S
    Curr Opin Rheumatol; 1992 Oct; 4(5):666-71. PubMed ID: 1419500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiphospholipid antibodies in arterial thrombosis.
    Koike T
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cardiolipin oxidation on solid-phase immunoassay for antiphospholipid antibodies.
    Schlame M; Haller I; Sammaritano LR; Blanck TJ
    Thromb Haemost; 2001 Dec; 86(6):1475-82. PubMed ID: 11776316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental models for antiphospholipid studies.
    Gharavi AE; Aron AL
    Haemostasis; 1994; 24(3):204-7. PubMed ID: 7988949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.
    Sthoeger ZM; Tartakovsky B; Bentwich Z; Mozes E
    J Clin Immunol; 1993 Mar; 13(2):127-38. PubMed ID: 7686561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticardiolipin antibodies block the inhibition by beta 2-glycoprotein I of the factor Xa generating activity of platelets.
    Shi W; Chong BH; Hogg PJ; Chesterman CN
    Thromb Haemost; 1993 Aug; 70(2):342-5. PubMed ID: 8236146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.
    de Laat B; Eckmann CM; van Schagen M; Meijer AB; Mertens K; van Mourik JA
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of antibodies to beta 2 glycoprotein I with the antiphospholipid syndrome: a meta-analysis.
    Najmey SS; Keil LB; Adib DY; DeBari VA
    Ann Clin Lab Sci; 1997; 27(1):41-6. PubMed ID: 8997456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.